Clinical Trial Update: Intravenous Ketamine Plus Neurocognitive Training for Depression [Phase 1, Phase 2]

View source ↗

Summary

A combined intravenous ketamine treatment with neurocognitive training for depression has completed Phase 1 and Phase 2 studies; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Rebecca Price | Conditions: Depression | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-01